Terumo Corporation (TYO:4543)
Japan
· Delayed Price · Currency is JPY 2,681.50
0.00 (0.00%)
Jun 26, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
Cardiac and Vascular Company | 624.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiac and Vascular Company Growth | 12.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Care Solutions Company | 211.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Care Solutions Company Growth | 6.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood and Cell Technologies Company | 200.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood and Cell Technologies Company Growth | 18.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Adjustments from | 298.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Adjustments from Growth | 20.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
Americas | 395.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Growth | 20.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 218.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 13.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 84.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 7.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia and Others | 120.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia and Others Growth | 7.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 217.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | 2.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
Cardiac and Vascular Company Adjusted Operating Profit | 154.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiac and Vascular Company Adjusted Operating Profit Growth | 15.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Care Solutions Company Adjusted Operating Profit | 22.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Care Solutions Company Adjusted Operating Profit Growth | -0.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood and Cell Technologies Company Adjusted Operating Profit | 26.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood and Cell Technologies Company Adjusted Operating Profit Growth | 164.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Adjustments from Adjusted Operating Profit | -712.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Adjustments from Adjusted Operating Profit Growth | 171.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiac and Vascular Company Production Result | 620.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiac and Vascular Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Care Solutions Company Production Result | 197.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Care Solutions Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood and Cell Technologies Company Production Result | 205.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood and Cell Technologies Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|